Is Big Pharma Getting Smaller?Does Pfizer’s consumer healthcare announcement herald a trend towards slimmer, more focused business models? Pfizer’s announcement that...
New challenge for industry – governments want bigger role in price setting and R&DThe “financial toxicity” posed by very expensive cancer therapies was a major talking point at the recent American Society of Clinical...
‘Brexit’ – into the unknown“there is no plan” In the current political and economic turmoil after the ‘Leavers’ won victory in the UK referendum on whether Britain...
‘Brexit’ – what would it mean for pharma?better in or better out? The announcement of June 23rd as the date for the referendum on whether Britain should remain in the EU has...
Pfizer acquisition of Allergan – last of the big spenders?...different approaches needed Pfizer’s planned acquisition of Allergan in a US$160 billion stock deal – the largest ever in the...